Free tool
Stocks listed on Nasdaq GS
We cover 22 companies listed on Nasdaq GS. The median market value in the group is $4.19B. Across the group, the median move over the past trading day is −0.23%. 100% of the 21 with a 200-day average trade above it. Price change over the past year runs from −22.1% to +275.5% across the middle 80 percent of the group, with a median of +69.9%.
Other lists in this group
Table
22 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| BZ | Kanzhun Limited | $8.42B | Mid cap | −16.97% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| SSRM | SSR Mining Inc. | $7.90B | Mid cap | +106.56% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| AUGO | Aura Minerals Inc. | $7.49B | Mid cap | +217.63% |
| PAGP | Plains GP Holdings, L.P. | $6.55B | Mid cap | +57.00% |
| EXLS | ExlService Holdings, Inc. | $5.72B | Mid cap | −14.91% |
| MKTX | MarketAxess Holdings Inc. | $5.72B | Mid cap | −12.08% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| LIFE | Ethos Technologies Inc. | $3.75B | Mid cap | +132.11% |
| WIX | Wix.com Ltd. Ordinary Shares | $3.44B | Mid cap | −39.66% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| IOSP | Innospec Inc. | $2.36B | Mid cap | +11.67% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.